Diamines and Chemicals Limited (**DACL**) is a premier Indian specialty chemicals manufacturer and a dominant market leader in the production of **Ethylene Amines**. Headquartered in **Vadodara, Gujarat**, the company serves as a critical link in the global chemical supply chain, providing essential building blocks for **APIs (Pharmaceuticals), Agro-chemicals, Resins, Water Treatment, and Petroleum additives**. DACL has evolved from a single-plant operation into a multi-location enterprise with a focus on **import substitution**, high-margin derivatives, and sustainable chemical synthesis. The company is listed on both the **BSE** and the **National Stock Exchange (NSE: DIAMINESQ)**. --- ### **Strategic Manufacturing Footprint & Infrastructure** The company operates through a hub-and-spoke manufacturing model in Gujarat’s chemical belt, supported by captive renewable energy. * **Vadodara Unit (Main Plant):** Located in the **PCC Area**, this facility houses the core production lines and the primary **R&D Center**. In **January 2026**, the company received a **Product Mix Consolidated Consent & Authorization (CC&A) Amendment** from the **GPCB**, allowing for enhanced industrial flexibility. * **Dahej Unit (DACL Fine Chem Limited):** A state-of-the-art facility at **Dahej-II Industrial Estate**. This unit commenced commercial production on **March 1, 2024**, focusing on specialty and formulation chemicals. * **Renewable Energy Integration:** To mitigate power costs and carbon footprint, DACL operates **Wind Turbine Generators (WTG)** with a capacity of **0.75 MW** in **Shikharpur, Kutch**, dedicated to captive consumption. * **Quality Standards:** The company maintains rigorous international certifications, including **ISO 9001:2015**, **ISO 14001:2015**, and **ISO 45001:2018** (renewed/received **February 2024**). --- ### **Product Portfolio & R&D Innovation Pipeline** DACL’s strategy centers on developing **environmentally friendly processes** and **import substitutes** to capture domestic market share from international competitors. #### **Core Chemical Processes** The company is currently optimizing and scaling products within the following categories: * **Ethylene Amines:** Researching alternate synthesis routes to improve yields and reduce costs. * **Advanced Synthesis:** Focused on **Hydrogenation, Ketonisation, and Ammonition** to create a diversified pipeline of derivatives. * **Lithium-based Derivatives:** A new focus area through the Dahej subsidiary to tap into high-growth technology sectors. #### **R&D Investment Metrics** DACL maintains a high R&D-to-turnover ratio to ensure long-term competitiveness. | Financial Year | Capital Expenditure (₹ Lakhs) | Revenue Expenditure (₹ Crores) | Total R&D Spend (₹ Crores) | % of Total Turnover | | :--- | :--- | :--- | :--- | :--- | | **2024-25** | **13.01** | **1.72** | **1.85** | **2.59%** | | **2023-24** | **75.31** | **2.02** | **2.77** | **2.66%** | | **2022-23** | **36.90** | **1.66** | **2.03** | **1.79%** | --- ### **Corporate Structure & Strategic Investments** The group structure is designed to facilitate specialized production and joint ventures for market expansion. | Entity | Relationship | Ownership | Status | | :--- | :--- | :--- | :--- | | **DACL Fine Chem Limited (DFCL)** | Subsidiary | **100%** | Operational (Specialty Chemicals) | | **KLJ Organic Diamines Limited (KODL)** | Associate/JV | **35%** | Pre-operative / Development Phase | **Capital Allocation & Funding:** * **Warrant Allotment:** In **October 2024**, the company allotted **9,06,390 warrants** at **₹552 per warrant**, aiming to raise **₹50.58 crore**. This capital is earmarked for **new product CAPEX**, R&D, and deleveraging the subsidiary. * **Subsidiary Support:** DACL invested **₹20 crore** in **DFCL** equity in **2025** and extended an inter-corporate loan of **₹5.68 crore** at **11.70% interest**. * **JV Funding:** An inter-corporate loan of **₹2.82 crore** was extended to **KODL** at **8% interest**. --- ### **Financial Performance & Capital Structure** While the company saw a peak in FY 2022-23, recent years reflect a stabilization phase amidst global market shifts. #### **Standalone Financial Summary** | Metric (₹ Crore) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Revenue** | **75.15** | **106.76** | **113.31** | | **Net Profit (PAT)** | **4.49** | **17.77** | **42.22** | | **Sales Volume (MT)** | **N/A** | **1,796.34** | **1,726.41** | #### **Key Financial Indicators** * **Dividend Policy:** Maintained a consistent return to shareholders, with a **25% final dividend** (**₹2.50 per share**) recommended for FY 2023-24. * **Liquidity:** Working capital is supported by **SBI** facilities totaling **₹1.95 crore**. Surplus funds are held in short-term deposits yielding **5%–5.10%**. * **Customer Concentration:** Management has successfully reduced dependency on its largest client, with revenue concentration dropping from **~14%** to **~9.6%** (**₹7.26 crore**) in the latest fiscal year. --- ### **Growth Strategy & Future Outlook** 1. **Capacity Expansion:** Utilizing proceeds from the **₹50.58 crore** warrant issue to fund the commercialization of new products and scale the **Dahej-II** facility. 2. **Product Diversification:** Moving beyond basic amines into **Formulation Chemicals** and **Value-Added Derivatives** to insulate margins from commodity price cycles. 3. **Operational Efficiency:** Implementing "Technology Absorption" initiatives to reduce the physical footprint of manufacturing units while increasing output. 4. **Talent Retention:** The **ESOP-2021** plan, with an in-principle approval for **2,00,000 shares**, aligns key personnel with the company’s long-term growth targets. --- ### **Risk Management & Mitigation Framework** DACL employs a structured risk oversight process, with quarterly reviews by the **Audit Committee**. * **Market Imbalance:** The Ethylene Amines sector faces a global demand-supply mismatch expected to last through **2024-25**. DACL mitigates this by focusing on niche, high-margin domestic applications. * **Currency Exposure:** The company manages significant **USD** payables (**$471,467** as of March 2024) through hedging and monitoring exchange rate volatility. * **Regulatory Shifts:** A provision of **₹4.62 Lakhs** has been made for the new **Indian Labour Codes** (effective **November 2025**), with further evaluations pending. * **Credit & Liquidity:** Credit risk is managed through strict counterparty limits, while liquidity is secured via rolling cash flow forecasts and committed bank lines. * **Defined Benefit Obligations:** The company manages a **Gratuity Plan** (capped at **₹20 Lakhs** per employee) and monitors interest rate risks that could impact the present value of these liabilities.